WLF: leave ethics out of approvals

Share this article:
Calls by bioethicists and environmentalists for the FDA to consider other decidedly unscientific factors, including ethics and healthcare costs, when deciding a product approval decision are “absurd,” according to two senior officers of the American Council on Science and Health writing in a Washington Legal Foundation legal opinion letter. They were responding to an earlier article appearing in the Baltimore Sun.
They claim there are already “too many non-science factors working on FDA drug professionals. ... The intrusion of ‘ethics' into the drug evaluation process would lead to increased regulation of the drug industry, probably to the point of regulating it out of existence.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what ...

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...